Lung cancer is a common malignancy and remains the leading cause of cancer-related
deaths in both men and women in the United States. Imaging plays an important role in the …

Lung cancer is the leading cause of cancer deaths in men and women in the United States.
Accurate staging is needed to determine prognosis and devise effective treatment plans …

Staging of non-small lung cancer (NSCLC) uses the TNM classification and is undertaken to
identify those patients who are surgical candidates, either initially or after chemo …

Accurately staging patients with lung cancer is important in determining treatment options
and prognoses. Staging allows the distinction of patients who are candidates for surgical …

The staging of non-small lung cancer has to be performed in an interdisciplinary approach
considering all clinical, radiological and histologic results. The staging using imaging …

Lung cancer remains the leading cause of cancer death among men and women in the
United States. In 2002 169,400 patients were diagnosed with lung cancer and 155,000 …

Primary lung cancer is the leading cause of cancer mortality in the world, largely prefaced by
the fact that patients with lung cancer often present with locally advanced or metastatic …

The stage of non-small cell lung cancer (NSCLC) determines that the treatment strategy and
proper staging lead to improved survival. Integrated positron emission tomography …

Correctly staging lung cancer is extremely important because the treatment options and the
prognosis differ significantly by stage. Several noninvasive imaging studies are available to …

Patients with newly diagnosed non-small cell lung cancer (NSCLC) need accurate tumor
staging in order to direct appropriate therapy and establish prognosis; the tumor is usually …